| ADDQoL | DTSQ | HFS-II | |||
PRO scores compared to patients on OADs In patients on injectables only In patients on injectables and OADs |
−1.06 * −0.67 ** |
−2.24 −1.69 * |
+7.81 * +2.22 | |||
PRO scores in patients on different OAD patterns Metformin + DPP-4 inhibitors Metformin + Sulfonylureas |
−2.66 −3.15 |
P < 0.05 |
28.7 25.6 |
P < 0.01 |
15.2 20.4 |
P = 0.06 |